Prescriptions of broad-spectrum antibiotics to outpatients do not match increased prevalence and antibiotic resistance of respiratory pathogens in Bavaria

• Autorzy: Borgmann S , Jakobiak T. , Gruber H. , Schroder H. , Sagel U.
• Języki publikacji: EN

Abstrakty

EN

In this study we present an analysis of prescription numbers of various antibiotic classes to Bavarian (Southern Gennany) outpatients between 2000 and 2006 compared to fluctuating resistance patterns in representative respiratory pathogens. Prescriptions of "narrow-spectrum" antibiotics (e.g. penicillins, macrolides) decreased by 39% while prescriptions of "broad-spectrum" antibiotics increased by 38%. The most prominent increase was for quinolones and cephalosporines class II. Prescriptions of these antibiotics exhibited prominent seasonal alterations suggesting that these drugs had been used for treatment of respiratory infections. In contrast, the numbers of S. pneumoniae and H. influenzae detected in respiratory specimen decreased. Almost constant resistance rates of S. pneumoniae for first line antibiotics do not justify an increased use of cephalosporins class II and quinolones. Compared to Europe and Gennany in general, consumption of antibiotics is low in Bavaria. Even at this low level we propose an education of physicians treating outpatients in a way to avoid an excessive use of antimicrobials.

Słowa kluczowe

EN

Streptococcus pneumoniae; Haemophilus influenzae; bacteria; human disease; antibiotic resistance; Bavaria; respiratory infection; respiratory pathogen

• Wydawca: -
• Czasopismo: Polish Journal of Microbiology
• Rocznik: 2009
• Tom: 58
• Numer: 2
• Opis fizyczny: p.105-110,fig.,ref.

Twórcy

autor

Borgmann S

• Synlab Medical Care Service, Medical Care Centre Weiden, Zur Kesselschmiede 4, D-92637 Weiden, Germany

autor

Jakobiak T.

autor

Gruber H.

autor

Schroder H.

autor

Sagel U.

Bibliografia

• Barger A., L. Schade, G. Krause and M.H. Kramer. 2008. Antibiotikaresistenzen: Erkennen, bewerten und bekämpfen. Dtsch. Ärzteblatt. 49:C2155-C2156.
• Borgmann S., M. Kist, T. Jakobiak, M. Reil, E. Scholz, C. von Eichel-Streiber, H. Gruber, J.S. Brazier and B. Schulte. 2008. Prevalence of erythromycin and quinolone resistant Clostridium difficile strain 001 in Southern Germany. Euro. Surveill. 13(49): pii: 19057.
• Ferech M., S. Coenen, S. Malhotra-Kumar, K. Dvorakov, E. Hendrickx, C. Suetens, H. Goossens and ESAC Project Group. 2006. European surveillance of antimicrobial consumption (ESAC): outpatient antibiotic use in Europe.J. Antimicrob. Chemother. 58: 401-407.
• Goossens H., M. Ferech, S. Coenen, P. Stephens and European Surveillance of Antimicrobial Consumption Project Group. 2006. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin. Infect. Dis. 44: 1091-1095.
• Goossens H., M. Ferech, R. Vander Stichele, M. Elseviers and ESAC Project Group. 2005. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 565: 579-587.
• Kern W.V., K. de With, K. Nink, M. Steib-Bauert, H. Schröder. 2006. Regional variation in outpatient antibiotic prescribing in Germany. Infection 34: 269-273.
• Kresken M. and Straube E. 2008. 4. Antibiotic resistance in human medicine (in German) 4.1.4. Haemophilus influenzae. In: Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Paul-Ehrlich-Gesellschaft für Chemotherapie e.V., Infektiologie Freiburg Eds. GERMAP 2008. Antibiotic resistance and consumption (in German). Antiinfectives Intelligence, Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH, Rheinbach, Germany.
• Muller A., S. Coenen, D.L. Monnet, H. Goossens and ESAC project group. 2007. European surveillance of antimicrobial consumption (ESAC): outpatient antibiotic use in Europe, 1998-2005. Euro. Surveill. 12: E071011.1.
• Schröder H. and Kern W.V. 2008 Antibiotic consumption in human medicine. 2.1. Antibiotic consumption in ambulalatory settings (in German). In: Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Paul-Ehrlich-Gesellschaft für Chemotherapie e.V., 8. Infektiologie Freiburg Eds. GERMAP 2008. Antibiotic resistance and consumption (in German). Antiinfectives Intelligence, Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH, Rheinbach, Germany.
• Van der Linden M., M. Imöhl and M.M. Reinert. 2008. 4. Antibiotic resistance in human medicine (in German). 4.1.1. Streptococcus spec. In: Bundesamt für Verbraucherschutz und Lebensmittelsicherheit, Paul-Ehrlich-Gesellschaft für Chemotherapie e.V., Infektiologie Freiburg Eds. GERMAP 2008. Antibiotic resistance and consumption (in German). Antiinfectives Intelligence, Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH, Rheinbach, Germany.